Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • fud.fighter2 fud.fighter2 May 18, 2014 12:58 PM Flag

    Could $13.85 today be $138.50 by next May?

    $138.50 x 48,000,000 shares would mean a valuation of $6,648,000,000.

    A valuation multiple of 9 x sales would require annual sales of $738,666,666 for that valuation.

    1. Cystic Fibrosis therapy will probably be priced upwards of $30,000 per patient per year (26 weeks on therapy).

    Target population (US and Europe): 30,000 with Pseudomonas.

    2. Therapy for TB and NTM will probably be priced around $35,000 for a six-month course.

    Target population (high-income countries): MDR-TB 30,000 / NTM 200,000.

    3. Therapy for Gram-negative pneumonia will probably be priced around $3,000 for a two-week course.

    Target population (US and Europe alone): 80,000.

    4. Just 20,000 six-month courses would mean sales of $700,000,000.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
11.36+0.43(+3.93%)Jul 27 4:00 PMEDT